Medical News

RSS

Data illustrates methods for improving adherence to medication, lowering prescription drug costs

CVS Caremark presented data at the 22nd Annual Meeting of the Academy of Managed Care Pharmacy that illustrate successful methods for improving adherence to medication and lowering prescription drug costs. The company showed results from three studies which demonstrated the positive impact of various tools available to pharmacy benefit managers – including automated telephonic messaging, fax alerts to physicians about gaps in care, and strategic co-pay waivers for generic medications.

8 Apr 2010

Health on the Hill - Early implementation challenges

Kaiser Health News staff writers Julie Appleby and Mary Agnes Carey talk with KFF's Jackie Judd about what is next for health reform.

8 Apr 2010

BIOTRONIK receives European approval for new ProMRI Pacing Systems

BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the European approval of its new ProMRI Pacing Systems — Evia pacemaker series and Safio S pacing leads — providing European patients the first portfolio of bradycardia systems that are compatible with Magnetic Resonance Imaging (MRI) scans under specific conditions.

8 Apr 2010

Women living in northeastern U.S. more likely to develop RA: Study

Women living in the northeastern United States are more likely to develop rheumatoid arthritis, suggesting a link between the autoimmune disease and vitamin D deficiency, says a new study led by a Boston University School of Public Health researcher.

8 Apr 2010

Baxa releases DoseEdge TPN for automated TPN production

Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release of DoseEdge TPN, the industry's first product for completely managing the workflow for automated TPN production.

8 Apr 2010

Health reform law raises hopes, issues for Medicaid

Changes coming because of the health reform law could affect the delivery of care for Medicaid patients.

8 Apr 2010

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).

8 Apr 2010

Allscripts' third-quarter revenues rise up 12%

Allscripts-Misys Healthcare Solutions, Inc. today announced its financial results for the three and nine months ended February 28, 2010.

8 Apr 2010

Arizona and Nevada Governors reject AGs' advice, join suit against new health law

The Associated Press/Boston Globe: "The governors of Arizona and Nevada say their states will join 14 others suing the federal government over health care reform. Gov. Jan Brewer announced Arizona was joining the suit Tuesday night. She signed a bill April 1 that gave her the authority to skirt the state's Democratic attorney general, Terry Goddard, who declined to sue on the state's behalf.

8 Apr 2010

Queensland Health pay bungle continues

Either you get overpaid or you don’t get paid at all, that’s how Queensland Health’s casual staff seem to feel. Last week a payroll system which was blamed for overpaying the Queensland Health Staff was replaced with a new one. The new system cost $40 million to develop, but in the opinion of the staff is worse than the old one. A number of them have not been paid at all.

8 Apr 2010

Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval

Torax Medical Inc., a medical device company focused on the minimally invasive treatment of gastro-esophageal reflux disease (GERD), has received CE Mark for its LINX® Anti-Reflux treatment. The company has started commercial launch of the LINX device at select centers in Europe.

8 Apr 2010

Today's opinions and editorials

From an economic perspective, health reform will fail if we can't sometimes push back against the try-anything instinct (David Leonhardt, 4/6).

8 Apr 2010

Is grandmother’s age significant to autism?

A report just published in the online journal, PLoS ONE, indicates that the mothers of children with an autistic spectrum disorder were themselves more likely to have been born to older mothers. These findings could open up new avenues in autism research.

8 Apr 2010

$Women unaware of risk of dangerous osteoporosis fractures$

Women unaware of risk of dangerous osteoporosis fractures

Only one in three Australian women diagnosed with osteoporosis are aware they are at higher risk of sustaining debilitating bone fractures, according to a landmark international study published with input from University of Sydney researchers.

7 Apr 2010

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.

7 Apr 2010

Valeant Pharmaceuticals International prices $400M of 7.625% senior unsecured notes due 2020

Valeant Pharmaceuticals International announced today that it has priced its previously announced private placement of $400 million of 7.625% senior unsecured notes due 2020. The principal amount was increased from the previously announced $350 million.

7 Apr 2010

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.

7 Apr 2010

Cytrx to commence Phase 2 trial of bafetinib for advanced prostate cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced plans to initiate a Phase 2 proof-of-concept clinical trial in the second half of 2010 to evaluate the effectiveness and safety of its oncology drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.

7 Apr 2010

DealSearchOnline.com announces $72.3B committed to fund 291 managed care mergers and acquisitions

More than $72.3 billion was committed to fund 291 managed care mergers and acquisitions announced during the 10-year period ended December 31, 2009, according to DealSearchOnline.com. UnitedHealth Group was the acquirer in 10 of the top 25 managed care mergers and acquisitions announced during 10-year period ended December 31, 2009.

7 Apr 2010

Low-skilled workers to perform initial blood donor screening: ONA, CFNU question decision

The Ontario Nurses' Association (ONA) has joined the Canadian Federation of Nurses Unions (CFNU) in questioning the decision of federal health minister Leona Aglukkaq to allow Canadian Blood Services to conduct a pilot project to replaces nurses with low-skilled workers for initial blood donor screening.

7 Apr 2010

Medical News

Data illustrates methods for improving adherence to medication, lowering prescription drug costs

Health on the Hill - Early implementation challenges

BIOTRONIK receives European approval for new ProMRI Pacing Systems

Women living in northeastern U.S. more likely to develop RA: Study

Baxa releases DoseEdge TPN for automated TPN production

Health reform law raises hopes, issues for Medicaid

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Allscripts' third-quarter revenues rise up 12%

Arizona and Nevada Governors reject AGs' advice, join suit against new health law

Queensland Health pay bungle continues

Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval

Today's opinions and editorials

Is grandmother’s age significant to autism?

Women unaware of risk of dangerous osteoporosis fractures

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

Valeant Pharmaceuticals International prices $400M of 7.625% senior unsecured notes due 2020

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Cytrx to commence Phase 2 trial of bafetinib for advanced prostate cancer

DealSearchOnline.com announces $72.3B committed to fund 291 managed care mergers and acquisitions

Low-skilled workers to perform initial blood donor screening: ONA, CFNU question decision

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News